Solvemed Group is a Neuroscience AI company working to redefine patient care and drug discovery. Our founders experienced first-hand the grave consequences of poor diagnostic standards in neurodegenerative diseases. With the primary focus in Parkinson’s disease, we leverage our proprietary machine learning technology to develop novel diagnostic-predictive digital biomarkers to enable first-in-class, accurate, early and cost-effective diagnostic and monitoring tools. We also revolutionise drug discovery as our biomarkers enable disease-modifying neurological drugs.
Página web: https://www.solvemedgroup.com/
United Kingdom